Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kcacdna
    Member
    • Sep 2009
    • 16

    Available for Sale: HiSeq X Five, NextSeq 500

    We currently have immediately available for sale Illumina NextSeq 500's, and Illumina HiSeq x five System. All NextSeq systems include de-installation, crating, re-licensing(software), re-certification, installation by Illumina. Must be in Lower 48 states. For Illumina re-cirtification, and licensing. Please let me know at your earliest convenience if interested.


    Contact me at [email protected]
  • GW_OK
    Senior Member
    • Sep 2009
    • 411

    #2
    Wow. I wonder who surplused $5M in instrumentation?

    Comment

    • kmcarr
      Senior Member
      • May 2008
      • 1181

      #3
      Originally posted by GW_OK View Post
      Wow. I wonder who surplused $5M in instrumentation?
      Someone who just bought a NovaSeq.

      Comment

      • GW_OK
        Senior Member
        • Sep 2009
        • 411

        #4
        Originally posted by kmcarr View Post
        Someone who just bought a NovaSeq.
        Well, yeah, but that's some serious capex burn.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        213 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        79 views
        0 reactions
        Last Post SEQadmin2  
        Working...